Asian Cohort for Alzheimer’s Disease (ACAD)
Observational Study
Get in touch about this studyFull study title: Asian Cohort for Alzheimer’s Disease (ACAD)
What is the study about?
This study aims to compile a robust sample of Asian American and Canadian subjects for Alzheimer’s disease (AD) research. Asians are the fastest-growing population in both countries, yet they are underrepresented in AD research. ACAD aims to address this gap by starting with a cohort of individuals of Chinese ancestry in Toronto and extending to other major Asian populations in both countries. We also study how genetics and other non-genetic factors of Asian people, may be associated with risks for developing dementia (severe memory problems) in their old age.
Eligibility – Who can participate?
Older adults with either:
–Alzheimer’s Disease
-Cognitively healthy people
All participants must:
-be age 60 or above
-Identify as Chinese or Chinese Canadian and lives in Canada
-Ability to communicate in English, Mandarin, or Cantonese
Time requirement
The study lasts for a maximum of 5 years, including initial participation and follow-up every two years. Each participation of the study will take 3-4 hours and can be completed in 1-2 visits. For participants with Alzheimer’s Disease, we require a study partner.
The participant will go through in-person and/or virtual interviews and assessments with the study team members and a physician, and will also provide blood (preferrable) or saliva samples. Compensation is provided for your and study partner’s time and effort.
The initial participation and follow-ups involves:
- Questionnaires (Demographics, early life experience and physical activities, health and family history, research participation experience)
- Functional assessment and several cognitive tests
- A brief neurological examination perform by a physician
- Provide blood(preferrable) or saliva samples
TDRA study investigator
Dr. Wai Haung (Ho) Yu
More information
TDRA Site:
University of Toronto,
